|
Immunogenicity
of Melan-A and influenza peptides. The numbers correspond
to the number of patients with T-cell responses to Melan-A, influenza,
or both. In total, 43 patients were evaluable for immune response.
|
Treatment
Group
|
Number
of Responder Patients
|
|
Total
|
Melan-A
|
Influenza
|
Both
|
|
All
patients (n=43)
|
16
|
13
|
10
|
7
|
saline
(n=6)
|
2
|
0
|
2
|
0
|
AS02B (n=12)
|
2
|
1
|
1
|
0
|
IFA (n=17)
|
12
|
12
|
7
|
7
|
AS02B
or IFA + IL-2 (n=8)
|
0
|
0
|
0
|
0
|
|
